All News

2020

April

Featured News / Apr 08, 2020

Novartis completes safety review and initiates update to the Beovu® prescribing information worldwide

Read More
João, a patient with chronic Chagas cardiomyopathy, Brazil.
Featured News / Apr 08, 2020

World Chagas Disease Day 2020

Novartis is committed to reimagining the fight against Chagas Disease and advocating for an integrated, end-to-end care approach.

Read More
Illustration of the coronavirus created at the Centers for Disease Control and Prevention (CDC)
Featured News / Apr 07, 2020

Coronavirus (COVID-19) news feed

Read More
Nurse wearing a mask and gloves
Featured News / Apr 07, 2020

Novartis COVID-19 Response Fund provides support to healthcare workers and communities

Novartis COVID-19 Response Fund is providing urgently-needed support for healthcare workers and communities in over 50 projects around the world.

Read More
Featured News / Apr 03, 2020

Novartis announces first European donation of hydroxychloroquine to Switzerland

Read More
Media Release / Apr 02, 2020

Novartis announces plan to initiate clinical study of Jakavi® in severe COVID-19 patients and establish international compassionate use program

Read More
Media Release / Apr 02, 2020

Novartis announces mutual agreement to terminate sale of Sandoz US generic oral solids, dermatology portfolio to Aurobindo

Read More

March

Media Release / Mar 28, 2020

Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment

Read More
Media Release / Mar 27, 2020

Novartis Cosentyx® gains positive CHMP opinion for new indication in the axial spondyloarthritis spectrum

Read More
Media Release / Mar 27, 2020

AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal muscular atrophy (SMA)

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More